Jim Greenwood

See the following -

Blue Ribbon Study Panel on Biodefense Calls for Action to Support SLTT Response to Biological Events

Press Release | Blue Ribbon Study Panel on Biodefense | October 11, 2018

America's hometown heroes are on the front line when responding to biological incidents. These include health care providers, public health professionals, EMTs, firefighters and police. But a new report from the Blue Ribbon Study Panel on Biodefense says the thousands of first responders at state, local, tribal, and territorial (SLTT) governments that form the backbone of our nation will have to fend for themselves for far too long until federal assets arrive to assist with response. Holding the Line on Biodefense: State, Local, Tribal, and Territorial Reinforcements Needed recommends eight key steps that will increase the capability of the SLTT public and private sectors to share with the federal government the burden of preparing for, responding to, and recovering from large-scale biological events.

Read More »

Blue Ribbon Study Panel On Biodefense Receives $2.5 Million Grant To Reduce Risk of Catastrophic Bioweapon Disease Outbreaks

Press Release | Blue Ribbon Study Panel on Biodefense | February 15, 2018

The Blue Ribbon Study Panel on Biodefense announced today a $2.5 million grant from the Open Philanthropy Project. The grant allows the Panel to continue its leadership role in assessing our nation’s biodefense, issuing recommendations and advocating for their implementation, and identifying viable avenues for needed change to policy. The grant comes amidst heightened global tensions as North Korea and other regimes seek to develop biological weapons. It also arrives on the 100th anniversary of a catastrophic influenza pandemic that took the lives of millions around the world, a stark reminder of the dangers of biological events.

Read More »

Blue Ribbon Study Panel Recognizes National Security Strategy, Calls for Comprehensive Approach

Press Release | Blue Ribbon Study Panel on Biodefense | December 21, 2017

Senator Joseph Lieberman and Governor Tom Ridge, the co-chairs of the Blue Ribbon Study Panel on Biodefense, today addressed the newly updated U.S. National Security Strategy and the emphasis it places on combatting biological threats to the country. “With the release of the National Security Strategy, the Administration is sending a strong message to our enemies that America takes the biological threat seriously,” said Sen. Lieberman and Gov. Ridge.

Read More »

New Alliance to Drive and Measure Industry Progress to Curb Antimicrobial Resistance

Press Release | International Federation of Pharmaceutical Manufacturers & Associations | May 18, 2017

 

Speaking at the B20 Health Conference in Berlin, IFPMA Director-General Thomas Cueni announced the launch of the AMR Industry Alliance, which will help give impetus to the life-sciences industry efforts to curb antimicrobial resistance. The threat of antimicrobial resistance causing drug-resistant infections is now more urgent than ever. It is estimated that, unless action is taken, the burden of deaths from antimicrobial resistance could be as high as 10 million lives each year by 2050 – more than cancer...

Read More »

Top White House Biodefense Official to Address Bipartisan Panel

Press Release | Blue Ribbon Study Panel on Biodefense | November 12, 2018

The Trump Administration recently released a National Biodefense Strategy to better defend the United States against myriad biological threats. The development and implementation of a comprehensive national biodefense strategy were among the top recommendations made by the bipartisan Blue Ribbon Study Panel on Biodefense in 2015. This Wednesday, November 14, the Panel will convene at the Hudson Institute in Washington, D.C. to gain a better understanding of how far the Executive Branch has come in implementing its National Blueprint for Biodefense.

Read More »